Paul Bunn

Dr. Bunn is a Distinguished Professor of Medicine and James Dudley Chair in Cancer Research, Division of Medical Oncology at the University of Colorado School of Medicine. Dr. Bunn previously served as section head of the US National Cancer Institute (NCI)-Navy Medical Oncology Branch, Head of the Division of Medical Oncology at the University of Colorado, and Director of the University of Colorado Cancer Center. Dr. Bunn was President of the American Society of Clinical Oncology (ASCO), as well as on its Board of Directors. He was also President of the American Association of Cancer Institutes (AACI) and has chaired the US Food and Drug Administration’s Oncologic Drugs Advisory Committee. Dr. Bunn served on the Board of Directors, as president and as CEO, of the International Association for the Study of Lung Cancer (IASLC), growing the IASLC to become a highly impactful, multidisciplinary organization that includes researchers and clinicians from all over the world. Dr. Bunn was also the Principal Investigator on the Specialized Program in Research Excellence in Lung Cancer (SPORE) grant funded by NCI to expand understanding of the biology of the disease, as well as to find new methods of diagnosis, prevention, and treatment. The author of hundreds of articles, reviews, and book chapters, Dr. Bunn’s work is credited with setting standards in the treatment of the disease.